Sound Pharmaceuticals
Facts
- HQ
- Seattle
- Sectors
- Biotech, Pharmaceuticals, Healthcare
- Founded
- 2001 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Sound Pharmaceuticals Inc Seattle business license
- Stage
- null
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Sound Pharmaceuticals
Sound Pharmaceuticals raises $30M to advance SPI-1005 (Ebselen) into mid/late trials for noise-induced hearing loss
Sound Pharmaceuticals is raising $30 million (with just over $4 million committed so far) to fund mid- and late-stage trials of SPI-1005, an Ebselen-containing drug aimed at preventing or reversing noise-induced hearing loss. Ebselen can enter the cochlea and cross the blood-brain barrier, so SPI-1005 is being advanced for hearing loss while the compound is also studied for other ear disorders and bipolar disorder.
Questions about Sound Pharmaceuticals
What is Sound Pharmaceuticals?
Seattle
Who invested in Sound Pharmaceuticals, and how much has it raised?
Members of Seattle Flow see Sound Pharmaceuticals' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Sound Pharmaceuticals based?
Sound Pharmaceuticals is headquartered in Seattle.
When was Sound Pharmaceuticals founded?
Sound Pharmaceuticals was founded in 2001.